The hemolytic lectin CEL-III forms transmembrane pores in the membranes of target cells. A study on the effect of site-directed mutation at Lys405 in domain 3 of CEL-III indicated that replacements of this residue by relatively smaller residues lead to a marked increase in hemolytic activity, suggesting that moderately destabilizing domain 3 facilitates formation of transmembrane pores through conformational changes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/09168451.2016.1176520 | DOI Listing |
Front Immunol
January 2025
Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, United States.
Sickle cell disease (SCD) is a devastating hemolytic disease, marked by recurring bouts of painful vaso-occlusion, leading to tissue damage from ischemia/reperfusion pathophysiology. Central to this process are oxidative stress, endothelial cell activation, inflammation, and vascular dysfunction. The endothelium exhibits a pro-inflammatory, pro-coagulant, and enhanced permeability phenotype.
View Article and Find Full Text PDFFish Shellfish Immunol
February 2025
Fisheries College, Guangdong Ocean University, Zhangjiang, Guangdong, 524088, China.
Rhamnose-binding lectins (RBLs) are key components of pattern recognition molecules involved in pathogen clearance during non-specific immune responses and play an important role in the immune response of Mollusca. Pinctada fucata martensii is an essential species for artificial seawater pearl cultivation in China. With the increasing pollution of seawater, the study of the immune function of P.
View Article and Find Full Text PDFSemin Immunol
November 2024
Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Harvard Medical School Center for Glycosciences, USA. Electronic address:
Allergy Asthma Proc
September 2024
From the Allergy and Immunology Service, Walter Reed National Military Medical Center, Bethesda, Maryland; and.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!